Read More Pharma Industry News Swiss pharma Orphan Technologies launches phase 1/2 clinical trial for OT-58 in classical homocystinuria Orphan Technologies, a Swiss pharmaceutical company, has officially dosed the first patients in its groundbreaking phase 1/2 clinical… bypharmanewsdailyFebruary 16, 2019